Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT(1A) and 5-HT(1B) receptors with WAY 100,635 and GR 127,935

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1159-1163

  Gobert, A ^a   Rivet, J M ^a   Cistarelli, L ^a   Millan, M J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Cortex; Microdialysis; Serotonin 5 HT autoreceptors

Indexed keywords

ANTIDEPRESSANT AGENT; AUTORECEPTOR; DOPAMINE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIALYSATE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; DRUG SELECTIVITY; FRONTAL CORTEX; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEROTONIN RELEASE; SEROTONINERGIC TRANSMISSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0031016880     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031159.x     Document Type: Article

References (29)

1. Artigas F., Perez V., and Alvarez E. (1994) Pindolol induces a rapid improvement of patients with depression treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51, 248-251.
2. 1A antagonists. Trends Neurosci. 19, 378-383.
3. Berman R. M., Darnell A. M., Miller H. L., Anand A., and Charney D. S. (1995) Randomized controlled trial of pindolol in treatment naive and treatment refractory depression. Soc. Neurosci. Abstr. 21, 977.
4. Blier P. and Bergeron R. (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15, 217-222.
5. 1B receptors. J. Pharmacol. Exp. Ther. 250, 37-43.
6. Cenci M. A., Kalén P., Mandel R. J., and Björklund A. (1992) Regional differences in the regulation of dopamine and noradrenaline release in the medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res. 581, 217-228.
7. 1A antagonist research. Drugs Future 18, 631-642.
8. Craven R., Grahame-Smith D., and Newberry N. (1994) WAY-100635 and GR127935 effects on 5-hydroxytryptamine-containing neurones. Eur. J. Pharmacol. 271, R1-R3.
9. 1B/D receptor antagonists. Neurosci. Lett. 188, 41-44.
10. 1A autoreceptors, in conscious rats. Soc. Neurosci. Abstr. 21, 859.
11. 1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex. Br. J. Pharmacol. 118, 681-689.
12. 1A receptor antagonist. Behav. Brain Res. 73, 337-353.
13. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol. 115, 1064-1070.
14. 3 (auto) receptors inhibit dopamine release in the frontal cortex of freely moving rats in vivo. J. Neurochem. 66, 2209-2212.
15. Hjorth S. (1996) (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. Eur. J. Pharmacol. 303, 183-186.
16. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)-penbutolol. J. Pharmacol. Exp. Ther. 265, 707-712.
17. 1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig. Neuropharmacology 34, 383-392.
18. Jordan S., Kramer G. L., Zukas P. K., Moeller M., and Petty F. (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine and fluvoxamine. Synapse 18, 294-297.
19. Malagié I., Trillat A.-C., Jacquot C., and Gardier A.M. (1995) Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur. J. Pharmacol. 286, 213-217.
20. 1C receptor activation in rats. Psychopharmacology (Berl.) 110, 140-144.
21. O'Donnell J. M., Frith S., and Wilkins J. (1994) Involvement of beta-1 and beta-2 adrenergic receptors in the antidepressant-like effects of centrally administered isoproterenol. J. Pharmacol. Exp. Ther. 271, 246-254.
22. 1B receptors. Nature 360, 161-163.
23. Pessia M., Jiang Z. G., North R. A., and Johnson S. W. (1994) Action of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654, 324-330.
24. Prisco S., Pagannone S., and Esposito E. (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J. Pharmacol. Exp. Ther. 271, 83-90.
25. 1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology 34, 377-382.
26. 1D receptor antagonist. Behav. Brain Res. 73, 157-161.
27. Stanford S. C. (1996) Prozac: panacea or puzzle? Trends Pharmacol. Sci. 17, 150-154.
28. Tanda G., Carboni E., Frau R., and Di Chiara G. (1994) Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl.) 115, 285-288.
29. 3 receptors mediate fluoxetine but not desipramine-induced increase of extracellular dopamine in the prefrontal cortex. Psychopharmacology (Berl.) 119, 15-19.